PharmSelex's Series A Round

PharmSelex raised a round of funding on July 07, 2008.

PharmaSelex (fka:GPC-Rx) focuses on the structure prediction of G-protein coupled receptors (GPCRs) to develop new GPCR-targeting drugs with reduced toxicity and enhanced selectivity. GPCRs are cell s…

Articles about PharmSelex's Series A Round: